{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Biomarker",
      "Bipolar",
      "Depression",
      "Glutamate",
      "Imaging",
      "Mood",
      "Neuropharmacology",
      "Synaptic plasticity"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "26432926",
  "DateCompleted": {
    "Year": "2016",
    "Month": "09",
    "Day": "29"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "04",
    "Day": "08"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2015",
        "Month": "10",
        "Day": "01"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.neubiorev.2015.09.013",
      "S0149-7634(15)00246-8"
    ],
    "Journal": {
      "ISSN": "1873-7528",
      "JournalIssue": {
        "Volume": "59",
        "PubDate": {
          "Year": "2015",
          "Month": "Dec"
        }
      },
      "Title": "Neuroscience and biobehavioral reviews",
      "ISOAbbreviation": "Neurosci Biobehav Rev"
    },
    "ArticleTitle": "Translating depression biomarkers for improved targeted therapies.",
    "Pagination": {
      "StartPage": "1",
      "EndPage": "15",
      "MedlinePgn": "1-15"
    },
    "Abstract": {
      "AbstractText": [
        "Mood disorders are among the most common medical conditions and cause amongst the greatest disease burden. Currently approved antidepressants target monoamine pathways; these medicines take many weeks to relieve symptoms, and most patients do not have sustained responses. This review will highlight recent advances in translational science identifying dysfunctional biochemical processes and neuronal circuits associated with mood disorders. We will also summarize strategies for targeting these pathways and for enhancing synaptic plasticity to develop most effective and rapidly acting antidepressant therapies."
      ],
      "CopyrightInformation": "Copyright \u00a9 2015 Elsevier Ltd. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Neuroscience Discovery, Janssen Pharmaceutical Companies of Johnson & Johnson, 3210 Merryfield Row, San Diego, CA 92121, United States. Electronic address: dbredt@its.jnj.com."
          }
        ],
        "LastName": "Bredt",
        "ForeName": "David S",
        "Initials": "DS"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Neuroscience Discovery, Janssen Pharmaceutical Companies of Johnson & Johnson, 3210 Merryfield Row, San Diego, CA 92121, United States."
          }
        ],
        "LastName": "Furey",
        "ForeName": "Maura L",
        "Initials": "ML"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Neuroscience Discovery, Janssen Pharmaceutical Companies of Johnson & Johnson, 3210 Merryfield Row, San Diego, CA 92121, United States."
          }
        ],
        "LastName": "Chen",
        "ForeName": "Guang",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Neuroscience Discovery, Janssen Pharmaceutical Companies of Johnson & Johnson, 3210 Merryfield Row, San Diego, CA 92121, United States."
          }
        ],
        "LastName": "Lovenberg",
        "ForeName": "Tim",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Neuroscience at Janssen Pharmaceutical Companies of Johnson & Johnson, 1125 Trenton Harbourton Rd, Titusville, NJ 08560, United States."
          }
        ],
        "LastName": "Drevets",
        "ForeName": "Wayne C",
        "Initials": "WC"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Neuroscience at Janssen Pharmaceutical Companies of Johnson & Johnson, 1125 Trenton Harbourton Rd, Titusville, NJ 08560, United States."
          }
        ],
        "LastName": "Manji",
        "ForeName": "Husseini K",
        "Initials": "HK"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Neurosci Biobehav Rev",
    "NlmUniqueID": "7806090",
    "ISSNLinking": "0149-7634"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antidepressive Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Biomarkers"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antidepressive Agents"
    },
    {
      "QualifierName": [
        "analysis"
      ],
      "DescriptorName": "Biomarkers"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Depressive Disorder"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Neuronal Plasticity"
    }
  ]
}